Charles Schwab Investment Management Inc. Increases Stake in Axsome Therapeutics, Inc. (NASDAQ:AXSM)
Charles Schwab Investment Management Inc. raised its holdings in shares of Axsome Therapeutics, Inc. (NASDAQ:AXSM – Free Report) by 1.7% during the 4th quarter, HoldingsChannel reports. The fund owned 328,034 shares of the company’s stock after acquiring an additional 5,438 shares during the quarter. Charles Schwab Investment Management Inc.’s holdings in Axsome Therapeutics were worth […]
